Document is current

Article History

First Online: 5 May 2023

Competing interests

: B.K. consults for TeraImmune and serves on the board for FreshTracks Therapeutics outside the submitted work. J.H.B. is a Scientific Co-Founder for GentiBio and Scientific Advisory Board member for GentiBio, a consultant for Bristol-Myers Squibb and Hotspot Therapeutics and has past and current research projects sponsored by Amgen, Bristol-Myers Squib, Janssen, Novo Nordisk, and Pfizer. J.H.B is a member of the Scientific Advisory Boards for La Jolla Institute for Immunology, Oklahoma Medical Research Foundation, a Section Editor for UpToDate, and owns stock in Omeros and Gentibio outside the submitted work.